World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
74031
World Ranking
1967
National Ranking
1117

Minesh P. Mehta publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Minesh P. Mehta sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,060 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Minesh P. Mehta D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Minesh P. Mehta sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Minesh P. Mehta is affiliated with the University of Maryland, Baltimore in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Pulmonary and Respiratory Medicine, Genetics, Radiology, Nuclear Medicine and Imaging, Oncology, and Radiation.

The scientist's work covers a range of main topics including:

  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Advanced Radiotherapy Techniques
  • Meningioma and schwannoma management
  • Lung Cancer Research Studies
  • Radiation Therapy and Dosimetry
  • Radiomics and Machine Learning in Medical Imaging

Minesh P. Mehta has contributed to several recent papers, among which are:

  • "Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions" (2020), published in Neuro-Oncology
  • "Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001" (2020), published in Journal of Clinical Oncology
  • "Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient" (2020), published in Journal of Clinical Oncology
  • "RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults" (2023), published in Journal of Clinical Oncology
  • "Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma" (2020), published in Journal of Clinical Oncology

The frequent co-authors collaborating with Minesh P. Mehta include:

  • Rupesh Kotecha
  • Matthew D. Hall
  • Michael D. Chuong
  • Alonso N. Gutiérrez
  • Yazmín Odia

Publication venues where Minesh P. Mehta frequently publishes are:

  • Neuro-Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • Radiotherapy and Oncology
  • Neuro-Oncology Advances

Best Publications

  • A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

    Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel

  • Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

    David W Andrews;Charles B Scott;Paul W Sperduto;Adam E Flanders

  • Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu

  • Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial

    Vinai Gondi;Stephanie L. Pugh;Wolfgang A. Tome;Chip Caine

  • Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

    Gregory Cairncross;Meihua Wang;Edward Shaw;Robert Jenkins

  • A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database

    Paul W. Sperduto;Brian Berkey;Laurie E. Gaspar;Minesh Mehta

  • Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

    Paul W. Sperduto;Samuel T. Chao;Penny K. Sneed;Xianghua Luo

  • Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

    Mark R. Gilbert;Meihua Wang;Kenneth D. Aldape;Roger Stupp

  • Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    Jan C. Buckner;Edward G. Shaw;Stephanie L. Pugh;Arnab Chakravarti

  • Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

    Monika E. Hegi;Lili Liu;James G. Herman;Roger Stupp

  • Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

    Gregory Cairncross;B. Berkey;Edward G. Shaw;Robert Brian Jenkins

  • Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

    Paul D. Brown;Stephanie Pugh;Nadia N. Laack;Jeffrey S. Wefel

  • Response assessment criteria for brain metastases: proposal from the RANO group

    Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani

  • American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy.

    Louis Potters;Brian Kavanagh;James M. Galvin;James M. Hevezi

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Patrick Y. Wen;Michael Weller;Eudocia Quant Lee;Brian M. Alexander

  • RANDOMIZED COMPARISON OF STEREOTACTIC RADIOSURGERY FOLLOWED BY CONVENTIONAL RADIOTHERAPY WITH CARMUSTINE TO CONVENTIONAL RADIOTHERAPY WITH CARMUSTINE FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME: REPORT OF RADIATION THERAPY ONCOLOGY GROUP 93-05 PROTOCOL

    Luis Souhami;Wendy Seiferheld;David Brachman;Ervin B. Podgorsak

  • Image guidance for precise conformal radiotherapy

    Thomas Rockwell Mackie;Jeff Kapatoes;Ken Ruchala;Weiguo Lu

  • A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis

    Richard M. Auchter;John P. Lamond;Eben Alexander;John M. Buatti

  • Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

    Lauren E. Abrey;Leah Ben-Porat;Katherine S. Panageas;Joachim Yahalom

  • Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial

    Christina A. Meyers;Jennifer A. Smith;Andrea Bezjak;Minesh P. Mehta

Frequent Co-Authors

Paul D. Brown
Paul D. Brown Mayo Clinic
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
Walter J. Curran
Walter J. Curran Emory University
John H. Suh
John H. Suh Cleveland Clinic
Patrick Y. Wen
Patrick Y. Wen Harvard University
Laurie E. Gaspar
Laurie E. Gaspar University of Colorado Denver
Susan M. Chang
Susan M. Chang University of California, San Francisco
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Timothy J. Kinsella
Timothy J. Kinsella Brown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative education pathways can be valuable for those interested in healthcare careers or looking to advance their qualifications. Online learning has opened doors to accelerated and flexible options. For registered nurses aiming to move forward in their careers, cheap rn to bsn online programs can make earning a bachelor's degree both accessible and affordable.

Individuals with a non-nursing background considering advanced nursing roles may benefit from entry level msn programs online. These programs allow students to quickly transition into nursing, often building on previous degrees in different fields.

For those seeking an easier admission process, options such as the easiest rn program to get into may provide broader access to nursing education, making it less competitive for motivated applicants.

Beyond nursing, non-clinical roles like medical billing and coding are also in high demand. Accredited schools offering medical billing and coding schools online with financial aid ensure that students can gain in-demand skills without significant financial burdens.

Best Scientists Citing Minesh P. Mehta

Trending Scientists

Recently Published Articles